[Federal Register: January 23, 2002 (Volume 67, Number 15)]
[Notices]               
[Page 3169]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23ja02-53]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Vaccine Against Ricin Toxin

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 5,453,271 entitled 
``Vaccine Against Ricin Toxin'' issued 04/05/95. This patent has been 
assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
Attn: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issue,s Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: It is now possible to immunize susceptible 
mammals against the pathological effect of exposure to ricin, including 
inhalation of ricin, by administration of an immunogenic effective 
amount of ricin toxin subunits, including subunits of both the A chain 
and the B chain of the ricin toxin given separately to provide safe, 
efficacious protection.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-1646 Filed 1-22-02; 8:45 am]
BILLING CODE 3710-08-M